Apraxia of Speech
22
6
7
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
67%
6 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (22)
taVNS for Speech and Language Recovery in Aphasia
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Using tDCS in Speech-based Stroke Rehabilitation
Motor Imagery for Treatment Enhancement and Efficacy in Persons With Apraxia of Speech
Investigating the Effects of Rhythm and Entrainment on Fluency in People With Aphasia
Measuring Aided Language Development
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech
Video Assisted Speech Technology to Enhance Motor Planning for Speech
MIRAA - Implementation of Intensive Rehabilitation of Aphasia and/or Apraxia of Speech in Swedish Healthcare
Searching of Apraxia of Speech in Children With Specific Language Impairment
Treatment Intensity - Apraxia of Speech
Efficacy of START (Startle Rehabilitation Therapy) in the Treatment Stroke-induced Aphasia/Apraxia
Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)
Efficacy of an Intervention for the Children With Severe Speech Sounds Disorders
A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes
Treatments of Acquired Apraxia of Speech